Catheter Precision, Inc. Revenue 2017–2025
Catheter Precision, Inc. annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Catheter Precision, Inc. revenue for the quarter ending March 31, 2026 was 432000, a 202.10% increase year-over-year.
- Catheter Precision, Inc. revenue for the twelve months ending March 31, 2026 was 1.0 M, a 150.74% increase year-over-year.
- Catheter Precision, Inc. annual revenue for 2025 was 819000, a 95.00% increase from 2024.
- Catheter Precision, Inc. annual revenue for 2024 was 420000, a 4.98% decrease from 2023.
- Catheter Precision, Inc. annual revenue for 2023 was 442000, a 3057.14% increase from 2022.
- Catheter Precision, Inc. annual revenue for 2022 was 14000.
Catheter Precision, Inc. (VTAK) — Frequently Asked Questions
Catheter Precision, Inc. (VTAK) is a publicly traded US company. It has a market capitalization of $2M. In fiscal 2025 it reported revenue of $819,000 and net income of -$17M. Explore VTAK's stock price, financial statements, earnings history, margins and key ratios below.
What is Catheter Precision, Inc.'s market cap?
Catheter Precision, Inc. (VTAK) has a market capitalization of $2M.
What is the VTAK stock price?
VTAK trades at $1.10 (+10.00% on the day).
How much revenue does Catheter Precision, Inc. make?
Catheter Precision, Inc. reported revenue of $819,000 in fiscal 2025.
Is VTAK profitable?
In fiscal 2025, Catheter Precision, Inc. reported net income of -$17M.